常见产品
Common Products相关产品
DSPE-PEG2000-FA,磷脂聚乙二醇叶酸,MW:2000
- 产品货号:E-2087196
- 发布时间:2023-11-21
- 产品CAS :N/A
- 产品规格:mg
- 产品纯度:≥95%
- 产品货期:现货下单后48小时内发货,定制产品4-8周。
- 运输条件:顺丰常规运输
货号:E-2087196
CAS:N/A
规格:mg
纯度:≥95%
生产商:瑞禧生物
DSPE-PEG-Folate,DSPE-PEG-FA,磷脂聚乙二醇叶酸
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[folate(polyethylene glycol)]
别名:DSPE PEG Folate, Folic acid PEG DSPE
产品结构:
产品说明:
货号:PS2-DEFA-1K,2K,3K,5K,10K。
外观:黄色、橙色至褐色固体。
溶解度::>5 mg/mL在热水,氯仿/甲醇,DMSO中。
稳定性:在-20°C下1年,干燥,避光。
CAS号:1236288-25-7。
分子量(PEG):1K,2K,3.4K,5K,10K。
处理和使用:
DSPE PEG FA应始终保持低温干燥状态。使用前立即准备新鲜溶液。
避免频繁解冻和冷冻。有关使用本产品的更多信息,请访问瑞禧生物官网。
存储条件:
DSPE PEG FA应在-20℃下储存。干燥。可在惰性气体下处理材料以获得良好稳定性。12个月后重新测试材料。
相关产品推荐:
DSPE-PEG-NH2, DSPE-PEG-COOH
DSPE-PEG-NHS ,DSPE-PEG-FA
DSPE-PEG-SH,DSPE-PEG-MAL
参考文献:
Bubble-generating nano-lipid carriers for ultrasound/CT imaging-guided efficient tumor therapy------ International Journal of Pharmaceutics(IF=3.862)
Nasopharyngeal cancer combination chemoradiation therapy based on folic acid modified, gefitinib and yttrium 90 co-loaded, core-shell structured lipid-polymer hybrid nanoparticles------ Biomedicine & Pharmacotherapy(IF=3.457)
Targeted delivery of in situ PCR-amplified Sleeping Beauty transposon genes to cancer cells with lipid-based nanoparticle-like protocells------ Biomaterials(IF=10.273)
Cancer cell targeting, controlled drug release and intracellular fate of biomimetic membrane-encapsulated drug-loaded nano-graphene oxide nanohybrids------ Journal of Materials Chemistry B(IF=4.776)
In vitro and in vivo evaluation of folate-mediated PEGylated nanostructured lipid carriers for the efficient delivery of furanodiene.
NIR stimulus-responsive core–shell type nanoparticles based on photothermal conversion for enhanced antitumor efficacy through chemo-photothermal therapy------ Nanotechnology(IF=3.404)
lipid nanobubbles as an ultrasound-triggered artesunate delivery system for imaging-guided,tumor-targeted chemotherapy.
Facile synthesis of biocompatible MoSe2 nanoparticles for efficient targeted photothermal therapy of human lung cancer------ RSC Advances(IF=2.963)
Inhalable dry powder prepared from folic acid-conjugated Docetaxel liposomes alters pharmacodynamic and pharmacokinetic properties relevant to lung cancer chemotherapy.
Near infrared radiated stimulus-responsive liposomes based on photothermal conversion as drug carriers for co-delivery of CJM126 and cisplatin------ Materials Science and Engineering C(IF=5.08)
Normalizing Tumor Microenvironment Based on Photosynthetic Abiotic/Biotic Nanoparticles------ ACS Nano(13.709)
A novel near-infrared triggered dual-targeted nanoplatform for mitochondrial combined photothermal-chemotherapy of cancer in vitro------ Nanotechnology(3.404)
Folate-decorated and NIR-triggered nanoparticles loaded with platinum(IV)-prodrug plus 5-fluorouracil for targeted and chemo-photothermal combination therapy.
Paclitaxel prodrug based mixed micelles for tumor-targeted chemotherapy------ RSC Advances(IF=2.963)
本产品仅用于研究用途,不用于人类或诊断用途。
在线留言
欢迎您访问“试剂家 | 纳米靶向科研平台”官方网站,请留下您的需求,我们会派专业人员及时与您联系,并为您提供相应的产品方案。